Mario Gabelli Johnson & Johnson Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Johnson & Johnson stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 96,581 shares of JNJ stock, worth $15 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

96,581

Previous 98,362 1.81%

Holding current value

$15 Million

Previous $14.4 Million 8.87%

% of portfolio

0.17%

Previous 0.17%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $259,099 - $298,103	-1,781 Reduced 1.81%	96,581 $15.7 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $880,862 - $962,615	-6,101 Reduced 5.84%	98,362 $14.4 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $1.4 Million - $1.47 Million	-9,033 Reduced 7.96%	104,463 $16.5 Million
Q3 2023 Nov 08, 2023	SELL	$155.75 - $174.48 $3.05 Million - $3.42 Million	-19,588 Reduced 14.72%	113,496 $17.7 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $1.27 Million - $1.36 Million	-8,199 Reduced 5.8%	133,084 $22 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $2.21 Million - $2.64 Million	-14,625 Reduced 9.38%	141,283 $21.9 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $121,271 - $136,101	757 Added 0.49%	155,908 $27.5 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $2.84 Million - $3.16 Million	17,607 Added 12.8%	155,151 $25.3 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $6.76 Million - $7.48 Million	40,201 Added 41.3%	137,544 $24.4 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $705,304 - $800,971	-4,460 Reduced 4.38%	97,343 $17.3 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $139,869 - $155,189	-897 Reduced 0.87%	101,803 $17.4 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $388,084 - $431,266	-2,403 Reduced 2.29%	102,700 $16.6 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $732,491 - $785,724	-4,593 Reduced 4.19%	105,103 $17.3 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $914,440 - $1.02 Million	-5,974 Reduced 5.16%	109,696 $18 Million
Q4 2020 Feb 05, 2021	SELL	$137.11 - $157.38 $445,607 - $511,485	-3,250 Reduced 2.73%	115,670 $18.2 Million
Q3 2020 Nov 06, 2020	SELL	$140.38 - $153.83 $628,200 - $688,389	-4,475 Reduced 3.63%	118,920 $17.7 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $1.3 Million - $1.57 Million	-10,118 Reduced 7.58%	123,395 $17.4 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $709,073 - $982,456	-6,380 Reduced 4.56%	133,513 $17.5 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $2.15 Million - $2.46 Million	-16,830 Reduced 10.74%	139,893 $20.4 Million
Q3 2019 Nov 01, 2019	SELL	$126.95 - $142.14 $650,745 - $728,609	-5,126 Reduced 3.17%	156,723 $20.3 Million
Q2 2019 Aug 02, 2019	BUY	$131.15 - $144.24 $2.14 Million - $2.36 Million	16,345 Added 11.23%	161,849 $22.5 Million
Q1 2019 May 02, 2019	SELL	$125.72 - $139.79 $3.38 Million - $3.76 Million	-26,863 Reduced 15.58%	145,504 $20.3 Million
Q4 2018 Jan 30, 2019	SELL	$122.84 - $147.84 $1.18 Million - $1.42 Million	-9,621 Reduced 5.29%	172,367 $22.2 Million
Q3 2018 Nov 02, 2018	SELL	$121.58 - $142.88 $134,467 - $158,025	-1,106 Reduced 0.6%	181,988 $25.1 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $914,245 - $1.01 Million	-7,657 Reduced 4.01%	183,094 $22.2 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $2.08 Million - $2.46 Million	-16,625 Reduced 8.02%	190,751 $24.4 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $5.29 Million - $5.79 Million	-40,299 Reduced 16.27%	207,376 $29 Million
Q3 2017 Nov 01, 2017	BUY	$129.47 - $135.38 $32.1 Million - $33.5 Million	247,675	247,675 $32.2 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account